750
Views
37
CrossRef citations to date
0
Altmetric
Review Article

Autoimmunity and the pathogenesis of type 1 diabetes

, &
Pages 51-71 | Received 06 May 2009, Accepted 17 Jan 2010, Published online: 15 Jun 2010
 

Abstract

Type 1 diabetes mellitus (TID) is an autoimmune genetic disease with unidentified environmental agents affecting its pathogenesis. Susceptibility is determined by the interaction of MHC and non-MHC genes in the thymus, primarily by the IDDM1 locus, which is extremely polymorphic and thus generates multitudes of predisposing and protective haplotypes for binding self-peptides. By presenting these peptide antigens to immature T-cells for activation and selection, most autoreactive cells will be deleted, but inefficient presentation and subsequent deficiencies of non-MHC genes allow some cells to escape to the periphery and to be eliminated by anergy or regulatory T-cells. T-cell dysregulation to a Th1 response with secretion of inflammatory cytokines promotes a self-perpetuating autoimmune cascade leading to overt disease unless blocked by suppressive cytokines from Th2-type cells. Since autoantibodies reflect target-cell destruction, early insulin autoantibodies may be transient due to benign insulitis induced by insulin or proinsulin. Multiple autoantibodies denote epitope spreading to cryptic autoantigens, likely involving posttranslational variants. Thus, the resulting T1D development requires coordinated abnormal variations, and this requirement limits its occurrence to a small minority of susceptible individuals.

Acknowledgements

We are most grateful for the thoughtful comments of the referee and editor. Their suggestions have considerably raised the quality of our manuscript. Special thanks are also due to Mr M.M. Vaska and Ms Denise Upton, Librarians, Health Sciences Library, University of Calgary, for outstanding assistance.

Declaration of interest

None of the authors have any conflicts of interest (commercial or otherwise) to declare with regard to the writing of this review. No specific funding or other form of support was used in the writing of this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.